1 Nuclear Stock That Could Power Your Retirement Income for Decades

Brookfield Asset Management is positioned to benefit from a nuclear market rebound driven by AI/data center power demand and global reactor expansion, with Westinghouse as a key catalyst. The company’s fee-bearing capital rose from $418 billion in 2022 to $603 billion in 2025, while fee-related earnings increased from $2.11 billion to $2.99 billion and distributable earnings from $2.10 billion to $2.69 billion. It also offers a 3.7% forward yield and has raised its payout annually since its 2022 spin-off, with management targeting $1.2 trillion in FBC by 2030.

Analysis

The key equity winner is not the obvious uranium/mineral lever, but the toll-taker on nuclear buildout. A Brookfield-style platform monetizes the capex cycle twice: first through fee-bearing capital growth as institutions reallocate toward infrastructure, then through operating optionality when strategic assets like Westinghouse become embedded in policy-driven procurement. That creates a more durable earnings stream than commodity exposure, because the monetization can continue even if uranium prices normalize or reactor orders slip between announcement and first steel.

The second-order implication is that the AI/data-center power shortage is pushing governments and utilities toward long-duration baseload solutions faster than public markets are pricing. That benefits the full supply chain: EPC contractors, specialized equipment makers, and fuel-cycle names, but also raises execution pressure on newer reactor designs, which remain a commercialization risk. If the Westinghouse-US policy relationship translates into orders, the market may begin valuing Brookfield more like an infrastructure compounder with a policy call option, not just an asset manager.

The main risk is that this is a long-duration story with multiple veto points: permitting, local financing, cost overruns, and election cycles. Near term, the stock can re-rate on headline flow, but the underlying cash-flow uplift to distributable earnings will likely be back-end loaded over years, not quarters. The consensus may be underestimating how much of the upside accrues to the financial sponsor rather than the industrial operator, but it may also be overestimating the speed at which nuclear announcements become realized cash flows.

Contrarianly, the cleanest trade may be to prefer BAM over the pure-play nuclear names until the cycle matures. The pure plays offer more torque, but they also embed the most dilution and financing risk if rates stay elevated. BAM gives investors a lower-volatility way to express the thesis while preserving upside from capital formation, M&A, and eventual project monetization.

Key Decisions for Investors

• Long BAM vs. CCJ on a 6-12 month horizon: express the nuclear rebuild through the fee/asset-light monetization layer rather than commodity beta; expect lower drawdown risk if project timelines slip.
• Accumulate BAM on pullbacks rather than strength; use any post-headline dip as entry because the next leg is likely driven by fundraising/FBC optics, not immediate reactor revenue.
• Pair trade: long BAM / short a basket of high-multiple SMR pure plays for a lower-volatility relative-value expression if rate sensitivity and financing risk reassert.
• Buy medium-dated BAM call spreads if you want event-driven upside into the next cadence of capital deployment and policy announcements; the convexity is better than outright stock if the thesis advances in stages.
• Avoid chasing CCJ after strength unless uranium spot is also confirming; the article’s real signal is infrastructure monetization, not a near-term commodity squeeze.